483 Document: SPR Therapeutics Inc., Feb 22, 2018

FDANews 483 SPR Therapeutics Inc. Feb 22 2018 top
Laureen M. Geniusz FDA Investigator

On Feb 22, 2018, the FDA inspected SPR Therapeutics Inc.'s Cleveland site. Explore the inspectional observations.